* Thorne Healthtech Inc THRN.OQ THRN.O is expected
to show a
rise in quarterly revenue when it reports results on August 8.
* The Summerville South Carolina-based company is expected
to
report a 22.1% increase in revenue to $68.46 million from
$56.07 million a year ago, according to the mean estimate from 4
analysts, based on Refinitiv data.
* Refinitiv's mean analyst estimate for Thorne Healthtech
Inc is
for earnings of 6 cents per share.
* The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 4 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for Thorne
Healthtech
Inc is $8, above its last closing price of $5.87.
This summary was machine generated August 5 at 02:06 GMT. All
figures in US dollars unless otherwise stated